Epidemiology Practice Questions

Q: What is the primary purpose of interventional studies in clinical research?

Testing Hypotheses. ***Testing Hypotheses*** - Interventional studies, such as **randomized controlled trials**, are specifically designed to **test cause-and-effect relationships** by actively intervening. - They aim to determine if a specific intervention (e.g., a drug, a therapy) produces a hypothesized outcome. *Confirming Hypotheses* - While interventional studies can confirm hypotheses, their primary role is not just confirmation but the initial **rigorous testing** of a hypothesis under controlled conditions. - Confirmation often implies that previous evidence already strongly supports the hypothesis. *Manipulating Hypotheses* - Hypotheses themselves are not "manipulated"; rather, the **variables** within the study design (e.g., treatment groups, dosages) are manipulated to test the hypothesis. - This option incorrectly applies the concept of manipulation to the hypothesis. *Formulating Hypotheses* - Hypothesis formulation usually occurs during the **observational research phase** or through literature review, *before* interventional studies are designed. - Observational studies or descriptive research are more typically used for generating new hypotheses.

Q: The time interval between diagnosis by early detection and diagnosis by other means is what?

Lead time. ***Lead time*** - **Lead time** refers to the interval between diagnosis by screening or early detection and the time at which the diagnosis would have been made by usual clinical presentation or other means. - A longer lead time in screening programs can make it seem like screened individuals live longer, even if the treatment efficacy is the same (known as **lead time bias**). *Incubation period* - The **incubation period** is the time from exposure to an infectious agent to the onset of symptoms for an infectious disease. - It is not related to the comparison of diagnosis times using different methods. *Serial interval* - The **serial interval** in epidemiology is the time between symptom onset in an infected person and symptom onset in a secondary case infected by the first person. - This concept is specific to the transmission dynamics of infectious diseases and not to diagnostic timing. *Latent period* - The **latent period** can refer to various concepts depending on the context; in infectious diseases, it's the time from infection to infectivity, or in chronic diseases, it can be the time from exposure to a causal agent to the development of detectable disease. - While it relates to disease progression, it specifically measures the time until detectability or infectivity, not the difference in diagnostic timings between early detection and other methods.

Q: What is the prevalence in a given population of 1000, where there are 50 new cases of lung cancer and 100 old cases of lung cancer in the same population?

15%. ***Correct: 15%*** - **Prevalence** is the proportion of a population living with a disease at a specific time point. It includes both new and existing (old) cases. - **Calculation:** Total cases = 50 (new cases) + 100 (old cases) = 150 cases - **Prevalence rate** = (150 / 1000) × 100% = **15%** - Prevalence answers the question: "What proportion of the population has the disease right now?" *Incorrect: 1.50%* - This value represents a calculation error, likely from dividing 150 by 10,000 instead of 1,000 - It underestimates the actual prevalence by a factor of 10 - Would only be correct if there were 15 total cases, not 150 *Incorrect: 150* - This is the **absolute count** of individuals with lung cancer (both new and old cases) - Prevalence must be expressed as a **proportion or percentage**, not a raw count - Raw counts cannot be compared across populations of different sizes *Incorrect: 13%* - This would only be correct if there were 130 total cases, not 150 - This miscalculation fails to properly sum the new cases (50) and old cases (100) - The arithmetic is incorrect: 50 + 100 ≠ 130

Q: Which of the following is considered the most reliable indicator of mortality in a population?

ASDR. ***ASDR (Age-Specific Death Rate)*** * **ASDR** is considered the most reliable indicator of mortality because it takes into account the different **age structures** of populations being compared. * It provides a more accurate picture of mortality by showing the number of deaths relative to the population in specific age groups, which is crucial for **epidemiological studies** and public health planning. *CDR (Crude Death Rate)* * The **CDR** is the total number of deaths in a given period divided by the total population, which can be misleading when comparing populations with different **age distributions**. * A high CDR in one population might be due to a larger proportion of elderly individuals, rather than higher actual mortality risk across all age groups. *PMR (Proportional Mortality Ratio)* * The **PMR** expresses the proportion of deaths due to a specific cause out of all deaths, rather than the risk of dying from that cause in the entire population. * It does not reflect the **absolute risk** of death and can be influenced by changes in other causes of death. *CFR (Case Fatality Rate)* * The **CFR** measures the proportion of people diagnosed with a specific disease who die from that disease within a certain period. * While useful for understanding the severity of a disease, it is not an indicator of overall mortality in a population but rather the **lethality** of a particular condition among those affected.

Q: A disease has three times more incidence in females as compared to males, with the same prevalence in both males and females. The TRUE statement is:

Increase fatality in women. ***Increase fatality in women*** - **Prevalence = Incidence × Duration of disease** - Given: Incidence in females = 3 × Incidence in males, but Prevalence is same in both - For males: Prevalence = I_m × D_m - For females: Prevalence = 3I_m × D_f - Since prevalences are equal: I_m × D_m = 3I_m × D_f - Therefore: **D_f = D_m/3** (females have 1/3 the disease duration of males) - **Shorter disease duration means worse survival and increased fatality in women** *More survival in women* - This would be incorrect because if women had better survival, their disease duration would be longer - With 3× higher incidence AND longer duration, the prevalence in women would be much higher than men, not equal - The equal prevalence despite higher incidence indicates women are dying faster (shorter duration) *Better prognosis in men* - While men do have longer disease duration (3× that of women), this option is vague - "Prognosis" could refer to recovery or survival, but the question specifically asks about the relationship between incidence and prevalence - The more precise statement is about increased fatality in women, which directly explains the epidemiological relationship *Less fatality in men* - This is essentially the same as saying "more survival in men" or "better prognosis in men" - While men do have less fatality (longer duration), the question stem focuses on the paradox of higher incidence in women with equal prevalence - The **key insight** is recognizing increased fatality in women, which is the direct answer to why higher incidence doesn't lead to higher prevalence

Q: The ability of a screening test to detect true positives is known as:

Sensitivity. ***Sensitivity*** - **Sensitivity** refers to the ability of a screening test to correctly identify individuals who truly **have a disease** (true positives). - A highly sensitive test will have a low rate of **false negatives**. - **Clinical application (SnNout)**: When a highly **sensitive** test is **negative**, it helps rule **out** the disease. *Specificity* - **Specificity** is the ability of a test to correctly identify individuals who do **not have the disease** (true negatives). - A highly specific test has a low rate of **false positives**. - **Clinical application (SpPin)**: When a highly **specific** test is **positive**, it helps rule **in** the disease. *Positive predictive value* - **Positive predictive value (PPV)** is the probability that an individual with a **positive test result** actually has the disease. - PPV is influenced by the **prevalence of the disease** in the population being tested. *Negative predictive value* - **Negative predictive value (NPV)** is the probability that an individual with a **negative test result** actually does not have the disease. - NPV is also affected by the **prevalence of the disease**; a lower prevalence generally leads to a higher NPV.

Q: A study is to be conducted to compare the fat content in the expressed breast milk of pre-term infants with that of term infants. Which study design is best suited?

Prospective cohort. ***Prospective cohort*** - Among the given options, a **prospective cohort study** is the most appropriate design for this comparative study. - The study involves identifying two groups (mothers of pre-term vs. term infants) and **prospectively collecting breast milk samples** to measure and compare fat content between these groups. - This design allows for **standardized data collection** moving forward in time, ensuring consistent measurement protocols for both groups. - While this is essentially a comparative cross-sectional measurement, the prospective nature ensures proper sample collection and reduces recall bias. *Case control* - This design is used to compare **exposures** between those with and without an outcome (typically a disease). - Fat content in breast milk is a **continuous biological variable**, not a disease outcome, making case-control design inappropriate. - Case-control studies work backward from outcome to exposure, which doesn't fit this scenario where we're comparing groups defined by infant term status. *Longitudinal study* - While **prospective cohort** is a type of longitudinal study, this term is too broad and non-specific. - Longitudinal studies involve repeated measurements over time, but this question asks for a specific study design for comparing two groups. - Simply stating "longitudinal study" doesn't specify the comparative framework needed. *Ambispective* - An **ambispective (or ambi-directional) study** combines retrospective and prospective components, using existing historical data plus new follow-up. - This design is unnecessary here as there's no indication of existing historical data to utilize. - The study can be conducted entirely prospectively by identifying mothers and collecting fresh breast milk samples for analysis.

Q: Which of the following is not a measure of reliability in screening tests?

Validity (accuracy of measurement). ***Validity (accuracy of measurement)*** - **Validity** refers to how accurately a test measures what it intends to measure, often assessed by comparing it to a **gold standard** - It is a measure of a test's **accuracy**, not its reliability or consistency when repeated - **This is NOT a measure of reliability** - it's a separate concept assessing whether the test identifies true positives and true negatives correctly *Consistency of results* - **Consistency of results** is a key aspect of reliability, indicating that the test yields similar outcomes under similar conditions - A reliable test should produce consistent results if repeated multiple times on the same individual (test-retest reliability) *Reproducibility of results* - **Reproducibility of results** is another term used to describe reliability, meaning that the test yields the same outcome when performed by different observers or in different settings - This ensures that the test results are not dependent on the administrator or environment (inter-rater/inter-observer reliability) *Precision of results* - **Precision of results** refers to how close repeated measurements are to each other, irrespective of whether they are close to the true value - It is a measure of the consistency and reliability of the test instrument or method

Q: Consanguineous marriages increase the risk of which of the following diseases?

Autosomal recessive diseases. ***Autosomal recessive diseases*** - Consanguineous marriages increase the likelihood of offspring inheriting two copies of a **recessive deleterious allele** from a common ancestor. - This significantly raises the risk of expressing **autosomal recessive conditions**, as both parents are more likely to be carriers of the same rare recessive gene. - Examples include **thalassemia, sickle cell disease, and cystic fibrosis**. *Autosomal dominant diseases* - These diseases manifest with only **one copy of the mutated allele**, regardless of consanguinity. - The risk is primarily linked to whether one parent carries the dominant gene, not the relatedness of the parents. *X linked dominant diseases* - These conditions are caused by mutations on the **X chromosome** and are expressed dominantly. - Consanguinity does not specifically increase the risk, as the disease manifests when the mutated X-linked gene is inherited from an affected parent. - The inheritance pattern depends on the affected parent's sex, not on parental relatedness. *Environmental diseases* - These diseases are primarily caused by **external factors** such as toxins, diet, lifestyle choices, or infections. - While genetic predisposition may play a role, consanguinity does not directly increase the risk for environmentally triggered diseases.

Q: Commonest carcinoma in men in tropical countries is

Ca oral cavity. ***Ca oral cavity*** - The high prevalence of **tobacco chewing** and **betel nut use** in many tropical countries significantly contributes to the high incidence of oral cavity cancer in men. - This habit is deeply ingrained in the **cultural practices** of these regions, leading to chronic irritation and carcinogenesis. *Ca rectum* - While colorectal cancer is common globally, it is generally **less prevalent** in tropical regions compared to oral cavity cancers attributed to specific lifestyle factors. - Its incidence is often linked to **Westernized diets** and sedentary lifestyles, which are not universally dominant in all tropical areas. *Ca testis* - Testicular cancer is more common in **younger men** in developed countries and is not typically the leading cancer in men across tropical regions. - It accounts for a **smaller proportion** of all male cancers globally compared to more prevalent cancers like oral cavity, lung, or prostate cancer. *Ca bladder* - Bladder cancer is often associated with **smoking** and occupational exposure to certain chemicals (e.g., dyes, rubber). - While present, it does not typically surpass the incidence of **oral cavity cancer** in tropical regions, where unique risk factors are highly prevalent.

Question 1

What is the primary purpose of interventional studies in clinical research?

Accepted Answer

Testing Hypotheses

Answer

Confirming Hypotheses

Answer

Manipulating Hypotheses

Answer

Formulating Hypotheses

Question 2

The time interval between diagnosis by early detection and diagnosis by other means is what?

Accepted Answer

Lead time

Answer

Incubation period

Answer

Serial interval

Answer

Latent period

Question 3

What is the prevalence in a given population of 1000, where there are 50 new cases of lung cancer and 100 old cases of lung cancer in the same population?

Accepted Answer

15%

Answer

1.50%

Answer

150

Answer

13%

Question 4

Which of the following is considered the most reliable indicator of mortality in a population?

Accepted Answer

ASDR

Answer

CDR

Answer

PMR

Answer

CFR

Question 5

A disease has three times more incidence in females as compared to males, with the same prevalence in both males and females. The TRUE statement is:

Accepted Answer

Increase fatality in women

Answer

More survival in women

Answer

Less fatality in men

Answer

Better prognosis in men

Question 6

The ability of a screening test to detect true positives is known as:

Accepted Answer

Sensitivity

Answer

Specificity

Answer

Positive predictive value

Answer

Negative predictive value

Question 7

A study is to be conducted to compare the fat content in the expressed breast milk of pre-term infants with that of term infants. Which study design is best suited?

Accepted Answer

Prospective cohort

Answer

Longitudinal study

Answer

Ambispective

Answer

Case control

Question 8

Which of the following is not a measure of reliability in screening tests?

Accepted Answer

Validity (accuracy of measurement)

Answer

Consistency of results

Answer

Reproducibility of results

Answer

Precision of results

Question 9

Consanguineous marriages increase the risk of which of the following diseases?

Accepted Answer

Autosomal recessive diseases

Answer

Autosomal dominant diseases

Answer

X linked dominant diseases

Answer

Environmental diseases

Question 10

Commonest carcinoma in men in tropical countries is

Accepted Answer

Ca oral cavity

Answer

Ca rectum

Answer

Ca testis

Answer

Ca bladder

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?